PMLiVE | Pharmaceutical industry news, articles, jobs, reports, …
WEBBayer presents positive results for Kerendia in late-stage heart failure study. Eli Lilly and HAYA Therapeutics enter metabolic condition partnership worth $1bn. Bayer and NextRNA Therapeutics enter oncology partnership worth $547m. J&J to expand cardiovascular capabilities with V-Wave acquisition worth up to $1.7bn.
AbbVie’s Rinvoq has ‘marginal clinical benefit’ over ... - PMLiVE
WEBNov 27, 2019 · According to ICER, this evidence demonstrates that Rinvoq provides a small to substantial health benenfit over Humira. The institute found that compared to the TNF blocker, Rinvoq’s value-based price benchmark is between $44,000 to $45,000 per year of treatment. This is a significant change from its initial cost-effectiveness threshold.
About us - PMLiVE
WEBBUSINESS DIRECTORTara Lovegrove Email: [email protected] Tel: +44 (0)1372 414 242. BUSINESS DEVELOPMENT. Eliot Haynes – Key Account Manager Email: [email protected] Tel: +44 (0)1372 414 220. EXECUTIVE DIRECTORKarl Equi Email: [email protected] Tel: +44 (0)1372 414 270. ADDRESSPMGroup Worldwide Ltd Mansard House Church Road Little Bookham ...
23rd PMEA celebrate excellence in pharmaceutical marketing
WEBNov 23, 2023 · PMEA returned for its 23rd year on 22 November to celebrate excellence in pharmaceutical marketing. This year’s Awards, held at the Sheraton Park Lane in London, kicked off with a networking event and saw the arrival of hundreds of guests who were dressed in smart evening wear and excited to support their respective companies. Being ...
Webinar: Understanding the patient journey in China - PMLiVE
WEBWebinar: Understanding the patient journey in China. The Chinese healthcare market is experiencing a period of great change. Utilising local knowledge and detailed case studies, this webinar examines the likely impact on the patient journey and considers the possible implications for market researchers. As the affluent middle-class continues to ...
Nerve centre gives Novartis edge in clinical trials - PMLiVE
WEBJan 30, 2019 · Algorithms predict potential delays. Novartis’ new nerve centre, the Sense tower, is a leap forward in managing clinical trials worldwide. The world’s biggest pharma companies are all in pursuit of a ‘digital transformation’ in their businesses, with the aim of using new technology and data to streamline operations, cut …
Bayer agrees $2.9bn deal for Algeta to get Xofigo control
WEBDec 19, 2013 · Bayer has reached an agreement to buy Norwegian pharma company Algeta after raising its offer to around $2.9bn. News of Bayer’s interest in Algeta – which developed recently-approved prostate cancer therapy Xofigo (radium Ra 223 dichloride) – first emerged in November when the offer was reported be NOK 336 per share, valuing the company at around $2.4bn.
How Russian lifestyles are affecting the nation’s healthcare
WEBOct 1, 2013 · Obesity is a health problem in Russia, as it is around the world. According to NHWS, 51 per cent of Russian urban adults are overweight or obese, and the mean body mass index (BMI) is 25.7, which is slightly lower than 5EU (52 per cent overweight/obese; mean BMI 26.1) and much lower than in the US (66 …
Edelman - PMLiVE
WEBEdelman. Our Mission To be the most trusted and admired integrated communications firm, where the best work is done on behalf of the most interesting brands and people. • We undertake our mission by integrating specialist practices and industry experts, local market understanding, proprietary methodology and breakthrough creativity.
PharmaVoxx - PMLiVE
WEBPharmaVoxx was founded in 2005 by a group of marketing and competitive intelligence (CI) professionals who have served the pharmaceutical industry for a combined 20 years. As pharma CI consultants to the pharmaceutical industry, we’ve monitored pharmaceutical communications in order to understand competitor positioning and predict competitor and market trends. PharmaVoxx was literally ...
Skip to content